Your phone could help doctors track MS better
NCT ID NCT05009160
Summary
This study aims to validate digital tools for tracking Multiple Sclerosis (MS) progression. Researchers are testing a smartphone app with 300 MS patients to see if it can reliably measure disease activity through daily challenges and monitoring. The goal is to create digital biomarkers that complement traditional doctor visits and MRIs for more continuous tracking of how MS affects daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Sclerosi Multipla, Ospedale Regionale di Lugano
Lugano, Switzerland, Switzerland
-
Department of Neurology, CHUV Lausanne
Lausanne, Switzerland, Switzerland
-
Klinik für Neurologie, Kantonsspital St. Gallen
Sankt Gallen, Switzerland, Switzerland
-
Klinik für Neurologie, Universitätsspital Zürich
Zurich, Switzerland, Switzerland
-
MS Center, Department of Neurology University Hospital Basel
Basel, Switzerland
-
Neurozentrum, Kantonsspital Aarau
Aarau, Switzerland, Switzerland
Conditions
Explore the condition pages connected to this study.